Her2 inhibition with neoadjuvant trastuzumab. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Cell Line, Tumor Axilla Esophagogastric Junction Lymph Nodes Neoplastic Cells, Circulating Bile Ducts, Intrahepatic

Organisms1

Diseases43

Breast Neoplasms Rectal Neoplasms Esophageal Neoplasms Adenocarcinoma Neoplasm Recurrence, Local Neoplasm Metastasis Carcinoma, Ductal, Breast Lymphatic Metastasis Carcinoma, Lobular Neoplasm, Residual Muscle Neoplasms Osteosarcoma Bone Neoplasms Carcinoma Carcinoma, Squamous Cell Neoplasm Invasiveness Stomach Neoplasms Disease Progression Urinary Bladder Neoplasms Sarcoma Pancreatic Neoplasms Neoplasms, Hormone-Dependent Carcinoma, Ductal Prostatic Neoplasms Carcinoma, Transitional Cell Liver Neoplasms Heart Diseases Lung Neoplasms Ovarian Neoplasms Meningeal Carcinomatosis Central Nervous System Neoplasms Nasopharyngeal Neoplasms Inflammatory Breast Neoplasms Neoplastic Cells, Circulating Cholangiocarcinoma Ureteral Neoplasms Neutropenia Carcinoma, Non-Small-Cell Lung Uterine Cervical Neoplasms Soft Tissue Neoplasms Recurrence Bile Duct Neoplasms Brain Neoplasms

Chemicals and Drugs54

Antibodies, Monoclonal, Humanized Receptor, erbB-2 Antibodies, Monoclonal Antineoplastic Agents Taxoids Anthracyclines Epirubicin Fluorouracil Paclitaxel Doxorubicin Maytansine Cyclophosphamide Cisplatin Deoxycytidine Vinblastine Receptors, Estrogen Biomarkers, Pharmacological Tumor Markers, Biological Receptors, Progesterone Quinazolines Bridged Compounds Antineoplastic Agents, Hormonal Nitriles Carboplatin Triazoles Ki-67 Antigen Cardiotoxins Fluorodeoxyglucose F18 Methotrexate Organoplatinum Compounds Androgen Antagonists Aromatase Inhibitors Antineoplastic Agents, Phytogenic Radiopharmaceuticals Flutamide Receptor, Epidermal Growth Factor Antimetabolites, Antineoplastic Receptor, erbB-3 Leucovorin Lead Radioisotopes Tamoxifen Actinium Ifosfamide Goserelin Immunoglobulin Subunits PTEN Phosphohydrolase Indium Radioisotopes Antibiotics, Antineoplastic Astatine Epothilones Prostate-Specific Antigen Protein Kinase Inhibitors Proto-Oncogene Proteins c-akt Tosyl Compounds

Analytical, Diagnostic and Therapeutic Techniques and Equipment72

Neoadjuvant Therapy Chemotherapy, Adjuvant Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Chemoradiotherapy, Adjuvant Neoplasm Staging Disease-Free Survival Combined Modality Therapy Radiotherapy, Adjuvant Esophagectomy Prognosis Survival Analysis Survival Rate Retrospective Studies Chemoradiotherapy Kaplan-Meier Estimate Cystectomy In Situ Hybridization, Fluorescence Drug Administration Schedule Immunohistochemistry Mastectomy Positron-Emission Tomography Prospective Studies Follow-Up Studies Tumor Burden Predictive Value of Tests Multimodal Imaging Mastectomy, Segmental Clinical Trials as Topic Clinical Trials, Phase II as Topic Xenograft Model Antitumor Assays Preoperative Care Remission Induction Lymph Node Excision Tomography, X-Ray Computed Randomized Controlled Trials as Topic Molecular Targeted Therapy Multivariate Analysis Infusions, Intravenous Proportional Hazards Models Fractionation, Field Flow Neoplasm Grading Feasibility Studies Radiotherapy Dosage Prostatectomy Clinical Trials, Phase III as Topic Magnetic Resonance Imaging Digestive System Surgical Procedures Pancreatectomy Radiotherapy, Conformal Patient Selection Sensitivity and Specificity Ultrasonography, Mammary Brachytherapy Animal Use Alternatives Hepatectomy Pilot Projects Nomograms Hysterectomy Risk Assessment Gene Expression Profiling Radiotherapy Biopsy Cohort Studies Pancreaticoduodenectomy Maximum Tolerated Dose Gastrectomy Risk Factors Neoplasm Transplantation Sentinel Lymph Node Biopsy Biopsy, Needle Radiotherapy, Intensity-Modulated

Phenomena and Processes16

Genes, erbB-2 Drug Resistance, Neoplasm Gene Expression Regulation, Neoplastic Gene Amplification Antibody-Dependent Cell Cytotoxicity Time Factors Drug Synergism Cell Proliferation Dose-Response Relationship, Drug Sensitivity and Specificity Signal Transduction Nomograms Maximum Tolerated Dose Genes, erbB Apoptosis Alpha Particles

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Information Science3

Survival Rate Radiotherapy, Conformal Radiotherapy, Intensity-Modulated

Health Care24

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Retrospective Studies Kaplan-Meier Estimate Prospective Studies Follow-Up Studies Predictive Value of Tests Clinical Trials as Topic Clinical Trials, Phase II as Topic Preoperative Care Randomized Controlled Trials as Topic Multivariate Analysis Proportional Hazards Models Feasibility Studies Clinical Trials, Phase III as Topic Patient Selection Sensitivity and Specificity Pilot Projects Nomograms Risk Assessment Cohort Studies Risk Factors

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Information Science Health Care

Neoadjuvant Therapy Antibodies, Monoclonal, Humanized Receptor, erbB-2 Breast Neoplasms Chemotherapy, Adjuvant Antineoplastic Combined Chemotherapy Protocols Antibodies, Monoclonal Antineoplastic Agents Treatment Outcome Taxoids Chemoradiotherapy, Adjuvant Genes, erbB-2 Anthracyclines Neoplasm Staging Disease-Free Survival Epirubicin Combined Modality Therapy Fluorouracil Paclitaxel Rectal Neoplasms Doxorubicin Maytansine Radiotherapy, Adjuvant Esophagectomy Cyclophosphamide Drug Resistance, Neoplasm Prognosis Cisplatin Deoxycytidine Esophageal Neoplasms Adenocarcinoma Survival Analysis Vinblastine Survival Rate Neoplasm Recurrence, Local Neoplasm Metastasis Carcinoma, Ductal, Breast Receptors, Estrogen Retrospective Studies Cell Line, Tumor Biomarkers, Pharmacological Chemoradiotherapy Tumor Markers, Biological Kaplan-Meier Estimate Receptors, Progesterone Lymphatic Metastasis Cystectomy Quinazolines Bridged Compounds Carcinoma, Lobular Antineoplastic Agents, Hormonal In Situ Hybridization, Fluorescence Drug Administration Schedule Nitriles Immunohistochemistry Neoplasm, Residual Mastectomy Muscle Neoplasms Positron-Emission Tomography Prospective Studies Carboplatin Osteosarcoma Follow-Up Studies Gene Expression Regulation, Neoplastic Tumor Burden Predictive Value of Tests Multimodal Imaging Triazoles Gene Amplification Antibody-Dependent Cell Cytotoxicity Mastectomy, Segmental Bone Neoplasms Carcinoma Carcinoma, Squamous Cell Clinical Trials as Topic Clinical Trials, Phase II as Topic Xenograft Model Antitumor Assays Ki-67 Antigen Cardiotoxins Neoplasm Invasiveness Stomach Neoplasms Fluorodeoxyglucose F18 Preoperative Care Methotrexate Organoplatinum Compounds Androgen Antagonists Disease Progression Urinary Bladder Neoplasms Mice, Nude Aromatase Inhibitors Antineoplastic Agents, Phytogenic Radiopharmaceuticals Remission Induction Lymph Node Excision Time Factors Tomography, X-Ray Computed Randomized Controlled Trials as Topic Sarcoma Flutamide Molecular Targeted Therapy

No FAQ available that match "her2 inhibition with neoadjuvant trastuzumab"